Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
Il sito "il Centro" utilizza cookie tecnici o assimiliati e cookie di profilazione di terze parti in forma aggregata a scopi pubblicitari e per rendere più agevole la navigazione, garantire la fruizione dei servizi, se vuoi saperne di più leggi l'informativa estesa, se decidi di continuare la navigazione consideriamo che accetti il loro uso.
Sab, Lug

Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

(Adnkronos) - Includes asymptomatic testing at community-based facilities to prevent widespread transmissions 

Regular testing for COVID-19, flu, RSV crucial for staying safe as anti-virus restrictions are eased 

PCR tests will be priced affordably, made possible through Seegene's 20 years of expertise 


support for countries that join Seegene's campaign to ensure safe return to normalcy" 

SEOUL, South Korea, May 25, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, today unveiled a global initiative for preemptive and routine PCR testing to help individuals stay safe and healthy while living in the COVID-19 era. Dr. Jong-Yoon Chun, CEO of Seegene, says the initiative is designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks. 

There have been reports of an uptick in influenza and everyday colds which had been absent during the two-year pandemic, as countries worldwide ease social distancing restrictions and lift mask mandates. Experts have also warned that potentially dangerous mutations could go unnoticed due to scaled down PCR testing with governments no longer providing them for free. Individuals are now required to monitor their health at their own expense to stay safe. 

Seegene's initiative dubbed 'In-life PCR,' entails 1) asymptomatic testing for early virus detection 2) syndromic respiratory testing as anti-virus restrictions are eased and 3) boosting PCR test accessibility through affordable pricing. 

"The '$12 PCR testing' campaign is expected to help Seegene deliver its commitment to making molecular diagnostics accessible to anyone," said Dr. Chun. "I'm certain that routine PCR testing will be the best solution to help end the COVID-19 pandemic. Seegene will provide full support for cities or countries that join hands with us to better track and curb the outbreak." 

Logo -   


Ho scritto e condiviso questo articolo
Author: Red AdnkronosWebsite: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.